The paper suggests a model for measuring the degree of openness of innovation in firms through the analysis of their annual reports. Two indicators are defined: open innovation generated value, which measures the intensity of outbound processes, and open innovation consumed value, measuring the intensity of inbound ones. The model is applied to a sample of 145 R&D intense companies in the biopharmaceutical industry, defining a positioning map of the firms in six classes.

Measuring Open Innovation in the Bio-Pharmaceutical Industry

MICHELINO, FRANCESCA;LAMBERTI, EMILIA;CAMMARANO, ANTONELLO;CAPUTO, Mauro
2015

Abstract

The paper suggests a model for measuring the degree of openness of innovation in firms through the analysis of their annual reports. Two indicators are defined: open innovation generated value, which measures the intensity of outbound processes, and open innovation consumed value, measuring the intensity of inbound ones. The model is applied to a sample of 145 R&D intense companies in the biopharmaceutical industry, defining a positioning map of the firms in six classes.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11386/4514270
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 43
social impact